Abstract:The acquisition of cancer hallmarks requires molecular alterations at multiple levels including genome, epigenome, transcriptome, proteome, and metabolome. In the past decade, numerous attempts have been made to untangle the molecular mechanisms of carcinogenesis involving single OMICS approaches such as scanning the genome for cancer-specific mutations and identifying altered epigenetic-landscapes within cancer cells or by exploring the differential expression of mRNA and protein through transcriptomics and proteomics techniques, respectively. While these single-level OMICS approaches have contributed towards the identification of cancer-specific mutations, epigenetic alterations, and molecular subtyping of tumors based on gene/protein-expression, they lack the resolving-power to establish the casual relationship between molecular signatures and the phenotypic manifestation of cancer hallmarks. In contrast, the multi-OMICS approaches involving the interrogation of the cancer cells/tissues in multiple dimensions have the potential to uncover the intricate molecular mechanism underlying different phenotypic manifestations of cancer hallmarks such as metastasis and angiogenesis. Moreover, multi-OMICS approaches can be used to dissect the cellular response to chemo- or immunotherapy as well as discover molecular candidates with diagnostic/prognostic value. In this review, we focused on the applications of different multi-OMICS approaches in the field of cancer research and discussed how these approaches are shaping the field of personalized oncomedicine. We have highlighted pioneering studies from “The Cancer Genome Atlas (TCGA)” consortium encompassing integrated OMICS analysis of over 11,000 tumors from 33 most prevalent forms of cancer. Accumulation of huge cancer-specific multi-OMICS data in repositories like TCGA provides a unique opportunity for the systems biology approach to tackle the complexity of cancer cells through the unification of experimental data and computational/mathematical models. In future, systems biology based approach is likely to predict the phenotypic changes of cancer cells upon chemo-/immunotherapy treatment. This review is sought to encourage investigators to bring these different approaches together for interrogating cancer at molecular, cellular, and systems levels.

Towards multi-omics characterization of tumor heterogeneity: a comprehensive review of statistical and machine learning approaches

Using Single‐cell Multiple Omics Approaches to Resolve Tumor Heterogeneity

Single-cell multi-omics sequencing and its application in tumor heterogeneity.

Advancing Breast Cancer Heterogeneity Analysis: Insights from Genomics, Transcriptomics and Proteomics at Bulk and Single-Cell Levels

Integrated Multi-Omics Analyses in Oncology: A Review of Machine Learning Methods and Tools

Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer

Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer

A narrative review of tumor heterogeneity and challenges to tumor drug therapy

An overview of multiomics: a powerful tool applied in cancer molecular subtyping for cancer therapy

Tumor Heterogeneity in Gastrointestinal Cancer Based on Multimodal Data Analysis

Machine learning for multi-omics data integration in cancer

A comprehensive review of machine learning techniques for multi-omics data integration: challenges and applications in precision oncology

Advances in single-cell omics and multiomics for high-resolution molecular profiling

Onco-Multi-OMICS Approach: A New Frontier in Cancer Research

Deconstructing intratumoral heterogeneity through multiomic and multiscale analysis of serial sections

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis

Multi-omics analysis: Paving the path toward achieving precision medicine in cancer treatment and immuno-oncology

Tumor Heterogeneity: The Challenge of Precision Medicine

Mapping Spatiotemporal Heterogeneity in Tumor Profiles by Integrating High-Throughput Imaging and Omics Analysis

Clinical multi-omics strategies for the effective cancer management

Histologically Resolved Multiomics Enables Precise Molecular Profiling of Human Intratumor Heterogeneity